132 related articles for article (PubMed ID: 36471533)
1. Letter to the Editor Regarding "Local ALK-Positive Histiocytosis with Unusual Morphology and Novel
Soylemez Akkurt T; Dur Karasayar AH; Gurbuz BC; Altınay S; Yuzkan S; Baskan F
Int J Surg Pathol; 2023 Oct; 31(7):1426-1429. PubMed ID: 36471533
[No Abstract] [Full Text] [Related]
2. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
[TBL] [Abstract][Full Text] [Related]
3. ALK-positive histiocytosis with
Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
[No Abstract] [Full Text] [Related]
4. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.
Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW
Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850
[TBL] [Abstract][Full Text] [Related]
5. Localised ALK-positive histiocytosis in lung with EML4::ALK fusion.
Zou L; Lu T; Li M; Wang A; Zhang Z; Pan B; Sun J
Pathology; 2024 Jun; 56(4):604-606. PubMed ID: 38097451
[No Abstract] [Full Text] [Related]
6. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast.
Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K
Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary ALK-rearranged soft tissue tumor with EML4-ALK gene fusion: report of a case].
Zhu YC; Zhang YJ; Zhang SK
Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1044-1046. PubMed ID: 37805400
[TBL] [Abstract][Full Text] [Related]
8. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.
Lucas CG; Gilani A; Solomon DA; Liang X; Maher OM; Chamyan G; Kleinschmidt-Demasters BK; Perry A
Acta Neuropathol; 2019 Aug; 138(2):335-337. PubMed ID: 31119374
[No Abstract] [Full Text] [Related]
9. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Kimura H; Nakajima T; Takeuchi K; Soda M; Mano H; Iizasa T; Matsui Y; Yoshino M; Shingyoji M; Itakura M; Itami M; Ikebe D; Yokoi S; Kageyama H; Ohira M; Nakagawara A
Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
[TBL] [Abstract][Full Text] [Related]
10. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.
Bai Y; Sun W; Niu D; Yang X; Diao X; Yu Y; Lin D
Virchows Arch; 2021 Dec; 479(6):1079-1083. PubMed ID: 33825946
[TBL] [Abstract][Full Text] [Related]
11. StALKing Histiocytosis: ALK-Positive Histiocytosis Identified through Peripheral Blood Smear.
Andolina JR
Acta Haematol; 2021; 144(3):241-243. PubMed ID: 32980847
[No Abstract] [Full Text] [Related]
12. Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.
Zheng D; Wang R; Zhang Y; Pan Y; Cheng X; Cheng C; Zheng S; Li H; Gong R; Li Y; Shen X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):833-43. PubMed ID: 26646246
[TBL] [Abstract][Full Text] [Related]
13. [Standard protocol of ALK fusion gene assessment by fluorescent in situ hybridization in non-small cell lung cancer].
Guo L; Zheng S; Xie YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):530-3. PubMed ID: 24246918
[TBL] [Abstract][Full Text] [Related]
14. ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.
Holsten T; Bronsema A; Sturm D; Sahm F; Rutkowski S; Schüller U; Wößmann W; Kordes UR
Pediatr Blood Cancer; 2022 Aug; 69(8):e29594. PubMed ID: 35195346
[No Abstract] [Full Text] [Related]
15. Construction of CTC-ALK gene fusion detection system based on the multi-site magnetic separation in lung cancer and its clinical verification.
Ma AP; Guo WX; Gao DH; Ke MY; Luo Q; Liu Q
Neoplasma; 2020 Nov; 67(6):1233-1243. PubMed ID: 32853016
[TBL] [Abstract][Full Text] [Related]
16. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC
J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003
[TBL] [Abstract][Full Text] [Related]
17. SEC31A-ALK Fusion Gene in Lung Adenocarcinoma.
Kim RN; Choi YL; Lee MS; Lira ME; Mao M; Mann D; Stahl J; Licon A; Choi SJ; Van Vrancken M; Han J; Wlodarska I; Kim J
Cancer Res Treat; 2016 Jan; 48(1):398-402. PubMed ID: 25715771
[TBL] [Abstract][Full Text] [Related]
18. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL
J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094
[TBL] [Abstract][Full Text] [Related]
19. ALK-Positive Histiocytosis: A Case Report and Literature Review.
Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
[TBL] [Abstract][Full Text] [Related]
20. RAS signaling in ALK fusion lung cancer.
Hrustanovic G; Bivona TG
Small GTPases; 2016; 7(1):32-3. PubMed ID: 26901483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
